US Patent 7964637 Process for producing optically active theaspirane
Patent 7964637 was granted and assigned to Takasago International Corporation on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+522 characters)
Article
Patent abstract
A simplified production method of stereoisomer of theaspiran having high optical purity has been desired. An alcohol compound having a specific skeleton is enantioselectively esterified with an enzyme, or an ester compound having a specific skeleton is enantioselectively hydrolyzed with an enzyme. The resultant optically active ester or optically active alcohol is used. Thus, optically active theaspiran having a desired configuration and having a high optical purity is obtained in a satisfactory yield.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Hiroyuki Matsuda0
Kenya Ishida0
Makoto Harada0
Yuichiro Yamazaki0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07964637 Process for producing optically active theaspirane US Patent 7964637 Process for producing optically active theaspirane
Infobox
Patent Number
079646370
Patent Number
79646370
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079646370
Date of Patent
June 21, 2011
0Patent Application Number
119920670
Date Filed
September 8, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07964637 Process for producing optically active theaspirane
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07964637
Date of patent
June 21, 2011
Patent application number
11992067
Date Filed
September 8, 2006
Patent primary examiner
Find more entities like US Patent 7964637 Process for producing optically active theaspirane
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
